ES8800209A1 - Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo - Google Patents

Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo

Info

Publication number
ES8800209A1
ES8800209A1 ES557310A ES557310A ES8800209A1 ES 8800209 A1 ES8800209 A1 ES 8800209A1 ES 557310 A ES557310 A ES 557310A ES 557310 A ES557310 A ES 557310A ES 8800209 A1 ES8800209 A1 ES 8800209A1
Authority
ES
Spain
Prior art keywords
alkyl
cpd
alkylcarbamoyl
iii
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557310A
Other languages
Spanish (es)
Other versions
ES557310A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59229938A external-priority patent/JPS61106593A/en
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES557310A0 publication Critical patent/ES557310A0/en
Publication of ES8800209A1 publication Critical patent/ES8800209A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anticancer compsn. comprises 5-fluorouracil (I) or a cpd. (II) capable of producing (I) in vivo together with a pyridine deriv. of formula (III). In (III) R1 = OH or acyloxy; R2, R4 = H, halogen, NH2, COOH, CONH2, CN, NO2, 1-6C alkyl, 2-6C alkenyl or (1-6C)alkoxycarbonyl; R3, R5 = H, OH or acyloxy. When at least one of R1, R3 and R5 = OH, then the 1-posn. of the (III) ring may have the -NH- structure by keto-enol tautomerism, and this H atom may be replaced by 1-6C alkyl, tetrahydrofuranyl, tetrahydropyranyl, (1-6C) alkoxy-(1-6C)alkyl, phthalidyl, CONH2, (1-6C)alkoxycarbonyl-(1-6C)alkylcarbamoyl, Ph-(1-6C)alkoxy-(1-6C)alkyl, phenylcarbamoyl (itself opt. ring substd.), (1-6C)alkylcarbamoyl, COOH-(1-6C)alkylcarbamoyl, (1-6C)alkylthio-(1-6C)alkyl or 2-6C alkenyl. Provided that (III) is not a cpd. of formula (IV), where R = H, 1-6C alkyl, tetrahydrofuranyl, tetrahydropyranyl, (1-6C)alkoxy-(1-6C)alkyl, (1-6C)alkylcarbamoyl, (1-6C)alkylthio-(1-6C)alkyl or 2-6C alkenyl.
ES557310A 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo Expired ES8800209A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP59229938A JPS61106593A (en) 1984-10-30 1984-10-30 2'-deoxy-5-fluorouridine derivative
JP25458784 1984-11-30
JP719085 1985-01-17
JP5978885 1985-03-25

Publications (2)

Publication Number Publication Date
ES557310A0 ES557310A0 (en) 1987-11-16
ES8800209A1 true ES8800209A1 (en) 1987-11-16

Family

ID=27454662

Family Applications (3)

Application Number Title Priority Date Filing Date
ES557310A Expired ES8800209A1 (en) 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo
ES557309A Expired ES8800213A1 (en) 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo
ES557311A Expired ES8800210A1 (en) 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557309A Expired ES8800213A1 (en) 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo
ES557311A Expired ES8800210A1 (en) 1984-10-30 1987-01-14 Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo

Country Status (1)

Country Link
ES (3) ES8800209A1 (en)

Also Published As

Publication number Publication date
ES8800210A1 (en) 1987-11-16
ES557309A0 (en) 1987-11-16
ES557310A0 (en) 1987-11-16
ES557311A0 (en) 1987-11-16
ES8800213A1 (en) 1987-11-16

Similar Documents

Publication Publication Date Title
ES407194A1 (en) 9,9-di-substituted -6,7-benzomorphans
GB1373536A (en) Hydroxypyrimidines
ES8800209A1 (en) Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo
ES8708141A1 (en) Anti-cancer compsn. contg. 5-fluoro-uracil or cpd. forming it in vivo
GB1347360A (en) Synchronising devices in motor vehicle cha'ge-speed gearing
ES396451A1 (en) 2-amino-4,5,7,8-tetrahydro-6h-thiazolo-or oxazolo(5,4-d) - azepines - as hypotensive, antiphlogistic, sedative and bechic agents
PT87728A (en) TROPICAL OIL COMPOSITIONS OF INCREASED VISCOSITY AND METHOD OF PREPARING SAME
GB1256977A (en)
ES2032942T3 (en) A PROCEDURE FOR PREPARING A MEDICATION FOR USE AGAINST ADENOCARCINOMAS.
FR2194436A1 (en) 3-formyloxindoles prepn - useful as medicaments for treating fatty degener-ation
GB1263929A (en) 2-substituted-4,5-diphenyl-oxazoles
JPS6431717A (en) Antitumor agent
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
ES394968A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
US4835182B1 (en)
USD205590S (en) Electronic cabinet
DE69006662D1 (en) Insulin preparation for non-parenteral administration.
ES373657A1 (en) Di-hydro triazine derivatives and processes for their manufacture
FR2150853A1 (en) 5,7-dimorpholino-pyrimido (4,5-d) pyrimidine derivs - diuretics
GB1293691A (en) TREATMENT OF MAREK'S DISEASE WITH p-AMINO-p'-UREIDODIPHENYL SULFONE
FR2035768A1 (en) Pyrimidine-based medicament having local - anaesthetic antitussive and antiinflammatory
USD82843S (en) Design fob a doll
USD235044S (en) Decorative panel for furniture door, drawer front, headboard or the like
AU621971B2 (en) Use of isocarbacyclins for preventing or treating organ diseases
IT1193506B (en) Neo:schizophyllan having a three-chain helicoidal conformation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060930